Allspring Global Investments
HBIO icon

Allspring Global Investments’s Harvard Bioscience HBIO Stock Holding History

Allspring Global Investments’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-145
Closed -$3.89K – 2036
2024
Q3 		$3.89K Sell
145
-935
-87% -$27.5K ﹤0.01% 2212
2024
Q2 		$30.8K Buy
+1,080
New +$37.9K ﹤0.01% 2036
2023
Q4 		– Sell
-2,883
Closed -$124K – 2436
2023
Q3 		$124K Buy
+2,883
New +$133K ﹤0.01% 1924
2022
Q3 		– Sell
-606
Closed -$21K – 2898
2022
Q2 		$21K Sell
606
-10,683
-95% -$482K ﹤0.01% 2473
2022
Q1 		$701K Sell
11,289
-11,557
-51% -$684K ﹤0.01% 2071
2021
Q4 		$1.61M Buy
+22,846
New +$1.62M ﹤0.01% 1657

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Allspring Global Investments's HBIO Position: Q4 2024 in Review

Allspring Global Investments sold out of Harvard Bioscience (HBIO) in Q4 2024, closing a stake of 145 shares — an estimated $3.89K sold.

Allspring Global Investments first reported a position in HBIO in Q4 2021 and held it in 6 quarters. The position peaked at $1.61M in Q4 2021. 95 funds tracked by Wall St. Rank hold HBIO as of Q4 2024.

  • Allspring Global Investments reported no remaining Harvard Bioscience position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 145 Harvard Bioscience shares in Q4 2024, an estimated $3.89K.
  • Allspring Global Investments first reported a position in Harvard Bioscience in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's Harvard Bioscience position peaked at $1.61M in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.